1-20 of 85
Nicola Cascavilla
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Description of a Clinical Score to Identify PMBL Patients at High Risk of Early-Failure after Rituximab Doxorubicin Back-Bone Chemoimmunotherapy. a FIL Real-World Study

Emilio Iannitto, Monica Balzarotti, Maurizio Martelli, Pier Luigi Zinzani, Alessandra Tucci, Alice Di Rocco, Federica Cavallo, Sara Usai, Anna Guidetti, Emanuele Ravano, Franceso Merli, Barbara Botto, Matteo Pelosini, Cristina Tecchio, Michele Spina, Enrico Derenzini, Silvia Finotto, Brunella Mola, Antonio Pinto, Manuela Zanni, Roberta Battistini, Stefan Hohaus, Irene Dogliotti, Guido Gini, Vittorio Ruggero Zilioli, Sonya De Lorenzo, Anna Dodero, Alessandro Broccoli, Alessandro Maggi, Clara Mannarella, Annalisa Chiarenza, Domenico Pastore, Pellegrino Musto, Caterina Stelitano, Francesco Di Raimondo, Nicola Cascavilla, Nicola Di Renzo, Marilena Salerno, Renato Scalone, Luca Nassi, Attilio Guarini, Caterina Patti, Vita Polizzi, Gabriella Amato, Giovannino Ciccone, Andrea Evangelista, Agostino La Porta, Angelo Genua, Donato Mannina, Ciro Maria Improta, Alessandro Re, Fabrizio Lo Presti, Rosalba Donatella Calogero, Maurizio Musso, Ugo Consoli
Journal: Blood
Blood (2023) 142 (Supplement 1): 986.
https://doi.org/10.1182/blood-2023-178197
Published: 2023
Journal Articles

Measurable Residual Disease Assessment in Patients with Acute Myeloid Leukemia Aged ≥60 Years Treated with a 10-Day Decitabine Schedule Versus Intensive Chemotherapy in the AML21 Study (NCT02172872)

Adriano Venditti, Michal Kicinski, Ernesta Audisio, Mario Luppi, Gianluca Gaidano, Robin Foà, Anna Candoni, Andrea Mengarelli, Attilio Olivieri, Annalisa Imovilli, Maurizio Musso, Paolo De Fabritiis, Eliana Zuffa, Nicola Cascavilla, Agostino Tafuri, Maria Ilaria Del Principe, Stefan Suciu, Anne Giraut, Stéphanie Antunes, Pierre W. Wijermans, Michael Lübbert, Geert A. Huls, Marco Vignetti, Francesco Buccisano
Journal: Blood
Blood (2023) 142 (Supplement 1): 2948.
https://doi.org/10.1182/blood-2023-184851
Published: 2023
Journal Articles

Ropeginterferon Alfa-2b Versus Standard Therapy for Low-Risk Patients with Polycythemia Vera. Final Results of Low-PV Randomized Phase II Trial

Tiziano Barbui, Alessandro M. Vannucchi, Valerio De Stefano, Arianna Masciulli, Alessandra Carobbio, Arianna Ghirardi, Greta Carioli, Elena Rossi, Fabio Ciceri, Massimiliano Bonifacio, Alessandra Iurlo, Francesca Palandri, Giulia Benevolo, Fabrizio Pane, Alessandra Ricco, Giuseppe Carli, Marianna Caramella, Davide Rapezzi, Caterina Musolino, Sergio Siragusa, Elisa Rumi, Andrea Patriarca, Nicola Cascavilla, Barbara Mora, Emma Cacciola, Carmela Mannarelli, Giuseppe Gaetano Loscocco, Paola Guglielmelli, Francesca Gesullo, Silvia Betti, Francesca Lunghi, Luigi Scaffidi, Cristina Bucelli, Nicola Vianelli, Marta Bellini, Maria Chiara Finazzi, Giovanni Tognoni, Alessandro Rambaldi
Journal: Blood
Blood (2022) 140 (Supplement 1): 1797–1799.
https://doi.org/10.1182/blood-2022-157255
Published: 2022
Journal Articles

Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma

Clinical Trials & Observations
Simone Ferrero, Daniele Grimaldi, Elisa Genuardi, Daniela Drandi, Gian Maria Zaccaria, Beatrice Alessandria, Marco Ghislieri, Martina Ferrante, Andrea Evangelista, Barbara Mantoan, Gabriele De Luca, Piero Maria Stefani, Fabio Benedetti, Ivana Casaroli, Manuela Zanni, Claudia Castellino, Vincenzo Pavone, Mario Petrini, Francesca Re, Stefan Hohaus, Gerardo Musuraca, Nicola Cascavilla, Chiara Ghiggi, Anna Marina Liberati, Sergio Cortelazzo, Marco Ladetto
Journal: Blood
Blood (2022) 140 (12): 1378–1389.
https://doi.org/10.1182/blood.2021014270
Published: 2022
Includes: Supplemental data
Journal Articles

Multicenter, Prospective and Retrospective Observational Cohort Study of Ponatinib in Patients with CML in Italy: Primary Analysis of the Oiti Trial

Massimo Breccia, Luigia Luciano, Mario Annunziata, Imma Attolico, Alessandra Malato, Elisabetta Abruzzese, Massimiliano Bonifacio, Anna Rita Scortechini, Nicola Cascavilla, Nicola Di Renzo, Stefana Impera, Monia Lunghi, Marco Santoro, Fausto Castagnetti, Alessandro Maggi, Valeria Sargentini, Alfonso Piciocchi, Claudia Galimberti, Alessandra Iurlo
Journal: Blood
Blood (2021) 138 (Supplement 1): 3603.
https://doi.org/10.1182/blood-2021-146139
Published: 2021
Journal Articles

The Accuracy of the International Myeloma Working Group Frailty Score in Capturing Health-Related Quality of Life Profile of Patients with Relapsed Refractory Multiple Myeloma

Fabio Efficace, Gianluca Gaidano, Maria Teresa Petrucci, Pasquale Niscola, Lucia Tognazzi, Elisabetta Antonioli, Francesco Cottone, Ombretta Annibali, Agostino Tafuri, Catello Califano, Alessandra Larocca, Leonardo Potenza, Giulia Palazzo, Claudio Fozza, Domenico Pastore, Gian Matteo Rigolin, Massimo Offidani, Alessandra Romano, Patrizia Tosi, Charalampia Kyriakou, Nicola Cascavilla, Stefano Molica, Alessandro Gozzetti, Daniele Derudas, Marco Vignetti, Michele Cavo
Journal: Blood
Blood (2021) 138 (Supplement 1): 115.
https://doi.org/10.1182/blood-2021-145977
Published: 2021
Journal Articles

Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma

Clinical Trials & Observations
Alessandra Larocca, Francesca Bonello, Gianluca Gaidano, Mattia D’Agostino, Massimo Offidani, Nicola Cascavilla, Andrea Capra, Giulia Benevolo, Patrizia Tosi, Monica Galli, Roberto Marasca, Nicola Giuliani, Annalisa Bernardini, Elisabetta Antonioli, Delia Rota-Scalabrini, Claudia Cellini, Alessandra Pompa, Federico Monaco, Francesca Patriarca, Tommaso Caravita di Toritto, Paolo Corradini, Paola Tacchetti, Mario Boccadoro, Sara Bringhen
Journal: Blood
Blood (2021) 137 (22): 3027–3036.
https://doi.org/10.1182/blood.2020009507
Published: 2021
Includes: Supplemental data
Journal Articles

Ixazomib-Based Induction Followed By Single-Agent Ixazomib Maintenance in Transplant Ineligible, Newly Diagnosed Multiple Myeloma Patients: Updated Results of the EMN10-Unito Trial

Roberto Mina, MD, Alessandra Larocca, Paolo Corradini, Nicola Cascavilla, Anna Marina Liberati, Norbert Pescosta, Francesca Fazio, Giovannino Ciccone, Andrea Capra, Francesca Patriarca, Annalisa Bernardini, Delia Rota Scalabrini, Michele Cea, Renato Zambello, Anna Baraldi, Angelo Belotti, Mario Boccadoro, Sara Bringhen, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-134671
Published: 2020
Journal Articles

Risk of Early Severe Infections in Newly Diagnosed Multiple Myeloma Patients Treated with Novel Agents: A Pooled Analysis

Francesca Bonello, Mattia D'Agostino, MD, Massimo Offidani, Maria Teresa Petrucci, Anna Marina Liberati, Francesca Patriarca, Andrea Capra, Giulia Benevolo, Gianluca Gaidano, Gregorio Barilà, Monica Galli, Elena Ponticelli, Nicola Cascavilla, Emanuele Angelucci, Stelvio Ballanti, Giuseppe Pietrantuono, Stefano Pulini, Daniele Derudas, Paolo de Fabritiis, Paolo Corradini, Concetta Conticello, Michele Cavo, Pieter Sonneveld, MD PhD, Mario Boccadoro, Sara Bringhen, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-136302
Published: 2020
Journal Articles

Predictive Model of Early Relapse in Newly Diagnosed Multiple Myeloma: Analysis from a Pooled Dataset

Gian Maria Zaccaria, PhD, Andrea Capra, Maria Teresa Petrucci, Massimo Offidani, Vittorio Montefusco, Francesco Di Raimondo, MD, Annalisa Bernardini, Anna Marina Liberati, Paola Omedé, Donato Mannina, Tommaso Caravita di Toritto, Vittorio Emanuele Muccio, Nicola Cascavilla, Stefania Montani, Francesca Patriarca, Giulia Benevolo, MD, Elona Saraci, Angelo Belotti, Gianluca Gaidano, MD PhD, Giorgina Specchia, MD, Arnon Nagler, MD MSc, Roman Hajek, Prof, MD PhD, Andrew Spencer, DM, Pieter Sonneveld, Mario Boccadoro, Francesca Gay, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2130.
https://doi.org/10.1182/blood-2019-125640
Published: 2019
Journal Articles

Sequential Matrix-RICE Therapy Followed By Autologous Stem Cell Transplant in Patients with Diffuse Large B-Cell Lymphoma and Secondary Central Nervous System Involvement: The International Extranodal Lymphoma Study Group-42 Phase II (MARIETTA) Trial

Andres JM Ferreri, MD, Jeanette K. Doorduijn, MD PhD, Chiara Cattaneo, MD, Maria Giuseppina Cabras, MD, Jeffery Smith, MBChB BMedSci MRCP FRCPath, Fiorella Ilariucci, Franco Narni, Teresa Calimeri, MD PhD, Alessandro Re, MD, Jahanzaib Khwaja, Barbara Botto, Claudia Cellini, MD, Luca Nassi, Kim Linton, MBChB PhD, Pam McKay, MD, Jacopo Olivieri, Caterina Patti, MD, Francesca Re, Alessandro Fanni, MD, Vikram Singh, MD, Jacoline Bromberg, MD, Kelly Cozens, Elisabetta Gastaldi, Nicola Cascavilla, Andrew Davies, MD PhD, Christopher P Fox, MBChB(Hons), MRCP, FRCPath, PhD, Maurizio Frezzato, MD, Wendy Osborne, MBBS, Anna Marina Liberati, Urban Novak, Renato Zambello, Emanuele Zucca, MD, Kate Cwynarski, PhDMD
Journal: Blood
Blood (2019) 134 (Supplement_1): 353.
https://doi.org/10.1182/blood-2019-129835
Published: 2019
Journal Articles

Azacitidine for Post-Remission Therapy in Elderly Patients with Acute Myeloid Leukemia : Final Results of the Qoless AZA-Amle Randomized Trial

Esther Natalie Oliva, MD, Anna Candoni, MD, Prassede Salutari, MD, Francesco Di Raimondo, MD, Gianluigi Reda, MD, Debora Capelli, MD, Pasquale Niscola, MD PhD, Carmine Selleri, MD, Pellegrino Musto, MD, Ernesto Vigna, MD, Antonio Volpe, MD, Nicola Cascavilla, Donato Mannina, MD, Paola Carluccio, MD, Maria Elena Zannier, MD, Elisa Mauro, MD, Alessandra Freyrie, MD, Carla Mazzone, MD, Bruno Martino, MD, Caterina Alati, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 117.
https://doi.org/10.1182/blood-2019-125562
Published: 2019
Journal Articles

Efficacy and Safety of Ixazomib-Dexamethasone, Ixazomib-Cyclophosphamide-Dexamethasone, Ixazomib-Thalidomide-Dexamethasone and Ixazomib-Bendamustine-Dexamethasone for Elderly Newly Diagnosed Multiple Myeloma (NDMM) Patients: Analysis of the Phase II Randomized Unito-EMN10 Study

Alessandra Larocca, Paolo Corradini, Roberto Mina, Nicola Cascavilla, Anna Marina Liberati, Norbert Pescosta, Maria Teresa Petrucci, Giovannino Ciccone, Andrea Capra, Francesca Patriarca, Delia Rota Scalabrini, Vanessa Innao, Marco Poggiu, Michele Cea, Renato Zambello, Anna Baraldi, Angelo Belotti, Claudia Cellini, Monica Galli, Mariella Grasso, Sara Aquino, Gloria Margiotta Casaluci, Giovanni De Sabbata, Stelvio Ballanti, Massimo Offidani, Katia Mancuso, Mario Boccadoro, Sara Bringhen
Journal: Blood
Blood (2019) 134 (Supplement_1): 3195.
https://doi.org/10.1182/blood-2019-124388
Published: 2019
Journal Articles

Outcome of Soft-Tissue Plasmocytomas in Newly Diagnosed Multiple Myeloma Patients Treated with New Drugs

Vittorio Montefusco, MD, Francesca Gay, MD, Stefano Spada, Lorenzo De Paoli, MD, Francesco Di Raimondo, MD, Rossella Ribolla, MD, Caterina Musolino, MD, Francesca Patriarca, MD, Pellegrino Musto, MD, Piero Galieni, MD, Michele Cavo, MD, Stelvio Ballanti, Chiara Nozzoli, MD, Nicola Cascavilla, MD, Dina Ben-Yehuda, MD, Arnon Nagler, MD, Roman Hajek, Massimo Offidani, MD, Anna Marina Liberati, MD, Paolo Corradini, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3235.
https://doi.org/10.1182/blood-2018-99-111482
Published: 2018
Journal Articles

Comprehensive Minimal Residual Disease (MRD) Analysis of the Fondazione Italiana Linfomi (FIL) MCL0208 Clinical Trial for Younger Patients with Mantle Cell Lymphoma: A Kinetic Model Ensures a More Refined Risk Stratification

Simone Ferrero, MD, Barbero Daniela, Mariella Lo Schirico, Andrea Evangelista, PhD, Annalisa Cifaratti, Daniela Drandi, PhD, Elisa Genuardi, PhD, Daniele Grimaldi, Luigia Monitillo, Gian Maria Zaccaria, PhD, Pietro Maria Stefani, Fabio Benedetti, Ivana Casaroli, Manuela Zanni, MD, Claudia Castellino, Vincenzo Pavone, Mario Petrini, PhD MD Prof, Francesca Re, MDPhD, Stefan Hohaus, Gerardo Musuraca, MD, Nicola Cascavilla, MD, Angela Giovanna Congiu, Anna Marina Liberati, MD, Giovannino Ciccone, MD, Umberto Vitolo, Sergio Cortelazzo, MD, Marco Ladetto, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 920.
https://doi.org/10.1182/blood-2018-99-114442
Published: 2018
Journal Articles

Ibrutinib, Single Agent BTK Inhibitor, for Treatment Naïve (TN) and Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia: A Real-Life Experience from Rete Ematologica Pugliese (REP)

Potito Rosario Scalzulli, MD, Attilio Guarini, MD, Giacomo Loseto, MD, Giorgina Specchia, Anna Maria Giordano, Domenico Pastore, MD PhD, Giovanni Quintana, MD, Patrizio Mazza, MD, Alessandro Maggi, Nicola Di Renzo, MD, Maria Rosaria De Paolis, Giuseppe Tarantini, Gaetano De Santis, MD, Vincenzo Pavone, Antonino Greco, MD, Maria Rosa Valvano, Statistician, Nicola Cascavilla, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5557.
https://doi.org/10.1182/blood-2018-99-116441
Published: 2018
Journal Articles

Health-Related Quality of Life Among Patients with Relapsed or Refractory Multiple Myeloma Who Received Pomalidomide, Bortezomib, and Low-Dose Dexamethasone Versus Bortezomib and Low-Dose Dexamethasone - Results from the Phase 3 Optimismm Study

Katja Weisel, MD, Meletios A Dimopoulos, MD, Philippe Moreau, Munci Yagci, Alessandra Larocca, MD, Abraham S. Kanate, MD, Filiz Vural, Nicola Cascavilla, MD, Supratik Basu, MBBS, MD FRCP, FRCPath, Peter Johnson, Peter D. Byeff, MD, Marek Hus, Paula Rodriguez Otero, MD, Kosei Matsue, MD PhD, Ercan Muelduer, Pekka Anttila, MD, Patrick Hayden, Maria-Theresa Krauth, MD, Dina Ben-Yehuda, MD, Larisa P. Mendeleeva, MD PhD Prof, Shien Guo, Lea Purnomo, Xin Yu, Lara Grote, Tsvetan Biyukov, MD, Mohamed Zaki, MD PhD, Paul Richardson
Journal: Blood
Blood (2018) 132 (Supplement 1): 1960.
https://doi.org/10.1182/blood-2018-99-112155
Published: 2018
Journal Articles

Phenotipic Heterogeneity Studied By Spade Algorithm in Relapsed/Refractory Acute Myeloid Leukemia

Giovanni Rossi, Vincenzo Giambra, PhD, Francesca Sansico, MD, Francesco Tamiro, MD, Vincenzo Chiello, MD, Patrizio Panelli, MD, Maria Marta Minervini, MD, Nicola Cascavilla, MD, Nicola Pio Sinisi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2793.
https://doi.org/10.1182/blood-2018-99-120109
Published: 2018
Journal Articles

Efficacy and Feasibility of Dose/Schedule-Adjusted Rd-R Vs. Continuous Rd in Elderly and Intermediate-Fit Newly Diagnosed Multiple Myeloma (NDMM) Patients: RV-MM-PI-0752 Phase III Randomized Study

Alessandra Larocca, MD, Marco Salvini, MD, Lorenzo De Paoli, MD, Nicola Cascavilla, MD, Giulia Benevolo, MD, Monica Galli, MD, Vittorio Montefusco, MD, Tommaso Caravita di Toritto, MD, Anna Baraldi, MD, Stefano Spada, Nicola Giuliani, MD PhD, Chiara Pautasso, Stefano Pulini, MD, Sonia Ronconi, MD, Norbert Pescosta, MD, Anna Marina Liberati, MD, Francesca Patriarca, MD, Claudia Cellini, MD, Patrizia Tosi, MD, Massimo Offidani, MD, Michele Cavo, MD, Antonio Palumbo, MD, Mario Boccadoro, MD, Sara Bringhen, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 305.
https://doi.org/10.1182/blood-2018-99-111796
Published: 2018
Journal Articles

Long Term Outcome of Lenalidomide-Dexamethasone (Rd) Vs Melphalan-Lenalidomide-Prednisone (MPR) Vs Cyclophosphamide-Prednisone-Lenalidomide (CPR) As Induction Followed By Lenalidomide-Prednisone (RP) Vs Lenalidomide (R) As Maintenance in a Community-Based Newly Diagnosed Myeloma Population: Updated Analysis of EMN01 Phase III Study

Sara Bringhen, MD, Massimo Offidani, MD, Pellegrino Musto, MD, Anna Marina Liberati, Giulia Benevolo, Nicola Cascavilla, MD, Mariella Genuardi, MD, Gianluca Gaidano, MD PhD, Donatella Zamagni, MD, Paola Ferrando, MD, Giovanni Pizzolo, Daniele Derudas, MD, Manuela Gambella, PhD, Alida Dominietto, MD, Ombretta Annibali, Giovanni Maria De Sabbata, MD, Attilio Gabbas, MD, Caterina Musolino, MD, Chiara Pautasso, Renato Zambello, MD, Giorgio La Nasa, MD, Laura Maracci, MD, Antonio Palumbo, MD, Roman Hájek, MD, Mario Boccadoro
Journal: Blood
Blood (2017) 130 (Supplement 1): 901.
https://doi.org/10.1182/blood.V130.Suppl_1.901.901
Published: 2017